It is a hallucinogenic drug, and is a controlled substance designed for use as an aesthetics. It also has now been touted for ...
Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.
Johnson & Johnson's Spravato nasal spray has been FDA-approved as a stand-alone therapy for adults with treatment-resistant ...
An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration ...
The announcement was welcome news for those with major depressive disorder, affecting an estimated 8.3% of the adult ...
"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...